CARLIE BEAN: Open Payments
NPI 1750859492 · LUBBOCK, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$929 in 30 payments from 13 companies in 2025. Trend: 2023 $645 · 2024 $612 · 2025 $929
Food & beverage: $929
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 5 | $290 |
| AstraZeneca Pharmaceuticals LP | 2 | $146 |
| Lilly USA, LLC | 6 | $128 |
| PFIZER INC. | 5 | $94 |
| Medtronic, Inc. | 1 | $70 |
| ABBVIE INC. | 2 | $38 |
| Exact Sciences Corporation | 2 | $37 |
| MAYNE PHARMA COMMERCIAL LLC | 2 | $28 |
| Daiichi Sankyo Inc. | 1 | $28 |
| Acella Pharmaceuticals, LLC | 1 | $19 |
Products named: Ozempic, Wegovy, AIRSUPRA, MOUNJARO, PREVNAR 20, INTERSTIM, VRAYLAR, INJECTAFER.
Industry payments across TX — which companies pay providers there.
